<p>This proposed book draws on the expertise of 35 experts in the field of Addiction Medicine to provide the reader with a current and comprehensive view of addiction as related to women, pregnancy, newborns, infants and children. The volume begins by placing current attitudes towards addicted women in a historical context, and continues with contributions on the relationship of gender to substance abuse research, addiction as a general health issue in women, and ethical dilemmas faced when approaching drug use during pregnancy.</p><p>The volume discusses high-risk pregnancies and HIV infection related to maternal drug abuse. It details specific pharmacotherapy such as methadone and buprenorphine, and assesses society’s punitive view toward illicit drug using women. Finally, the book describes outcomes of newborns, infants and children born following intrauterine drug exposure.</p><p>Health providers in many related disciplines, specialists in Addiction Medicine, social workers and ethicists are among those who will gain insight into the complex interdisciplinary matrix of abuse in women, its unique relationship to pregnancy, and its impact on drug-exposed children.</p><p>This book was published as a special issue in the<em> Journal of Addictive Diseases</em>.</p> <p>1. Introduction to Women, Children and Addiction <em>Loretta P. Finnegan </em>2. Women and Drug Addiction: A Historical Perspective <em>Stephen R. Kandall </em>3. Women and Addiction: The Importance of Gender Issues in Substance Abuse Research <em>Ellen Tuchman </em>4. Substance Use and Women’s Health <em>Abigail Kay</em>, <em>Trusandra E. Taylor</em>, <em>Andrea G. Barthwell</em>, <em>Jana Wichelecki</em>, and <em>Vera Leopold </em>5. Ethical Issues and Addiction <em>Binta Lambert</em>, <em>Melissa Scheiner</em>, and <em>Deborah Campbell </em>6. Addiction in Pregnancy <em>Joan Keegan</em>, <em>Mehdi Parva</em>, <em>Mark Finnegan</em>, <em>Andrew Gerson</em>, and <em>Michael Belden </em>. Human Immunodeficiency Virus Risk Behavior Among Female Substance Abusers <em>Susan E. Ramsey</em>, <em>Kathryn M. Bell</em>, and <em>Patricia A. Engler </em>8. Pharmacotherapy in the Treatment of Addiction: Methadone <em>Mary Jeanne Kreek</em>, <em>Lisa Borg</em>, <em>Elizabeth Ducat</em>, and <em>Brenda Ray </em>9. Gender Issues in the Pharmacotherapy of Opioid-Addicted Women: Buprenorphine <em>Annemarie Unger</em>, <em>Erika Jung</em>, <em>Bernadette Winklbaur</em>, and <em>Gabriele Fischer </em>10. Punishing Pregnant Drug-Using Women: Defying Law, Medicine, and Common Sense <em>Jeanne Flavin</em> and <em>Lynn M. Paltrow </em>11. Prenatal Drug Exposure: Infant and Toddler Outcomes <em>Emmalee S. Bandstra</em>, <em>Connie E. Morrow</em>, <em>Elana Mansoor</em>, and <em>Veronica H. Accornero </em>12. Children of Addicted Women <em>Barry M. Lester</em> and <em>Linda L. Lagasse</em></p>